Synergy CHC Corp. (SNYR)
| Market Cap | 4.24M |
| Revenue (ttm) | 30.38M |
| Net Income (ttm) | -12.34M |
| Shares Out | 11.30M |
| EPS (ttm) | -1.27 |
| PE Ratio | n/a |
| Forward PE | 2.89 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 350,074 |
| Open | 0.380 |
| Previous Close | 0.388 |
| Day's Range | 0.370 - 0.394 |
| 52-Week Range | 0.370 - 4.000 |
| Beta | 1.47 |
| Analysts | Strong Buy |
| Price Target | 6.25 (+1,564.45%) |
| Earnings Date | May 14, 2026 |
About SNYR
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; beauty products for the eyes, lips, brows, cheeks, and skin under the Perfekt Beauty brand; s... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for SNYR stock is "Strong Buy." The 12-month stock price target is $6.25, which is an increase of 1,564.45% from the latest price.
News
Synergy CHC Earnings Call Transcript: Q4 2025
2025 saw revenue decline due to a terminated international license and several one-time charges, but strategic progress was made with a new Mexican subsidiary and strong early 2026 beverage sales. Gross margin is expected to stabilize, with growth initiatives focused on Mexico and beverages.
Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
NORTH WINDHAM, Maine, April 01, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for ...
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
WESTBROOK, Maine, March 30, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced an updated date for ...
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
WESTBROOK, Maine, March 17, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that it plans to rel...
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
WESTBROOK, Maine, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced a major expansion of ...
Synergy CHC Earnings Call Transcript: Q3 2025
Q3 2025 saw double-digit revenue growth, higher gross margins, and continued profitability, supported by new leadership, expanded distribution, and a successful equity raise. Beverage and supplement segments both advanced, with major retail launches planned for 2026.
Synergy CHC Corp Expands FOCUSfactor® Functional Beverage Distribution Across Arkansas Through Partnership with C&M Sales
WESTBROOK, Maine, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with C&M Sale...
Synergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama
WESTBROOK, Maine, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with AlaBev,...
Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
WESTBROOK, Maine, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the closing of an und...
Synergy CHC Corp. Announces Pricing of $4.375 Million Public Offering
WESTBROOK, Maine, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the pricing of an und...
Synergy CHC Earnings Call Transcript: Q2 2025
Profitability continued for a 10th straight quarter, with net income up 125% and EPS up 86% year-over-year. Major distribution wins and international expansion are expected to drive further growth, while debt refinancing has improved financial flexibility.
Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability
WESTBROOK, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, is announcing its financial results for the t...
Synergy CHC Transcript: AGM 2025
The meeting followed a set agenda, with a quorum established and all proposals—including director elections, auditor ratification, equity plan amendment, and preferred stock authorization—approved by shareholders. Final voting results will be filed with the SEC.
Synergy CHC (NASDAQ: SNYR) Taps Former Coca-Cola Executive to Help Drive FOCUSfactor Energy Drink Global Expansion
WESTBROOK, Maine, June 10, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a fast-growing consumer health and wellness company, announced today that Damian Mara...
Synergy CHC Announces New $20 Million Long-Term Credit Facility
WESTBROOK, Maine, June 04, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it ha...
Synergy CHC Earnings Call Transcript: Q1 2025
Q1 2025 saw a 30% EPS increase and expanded EBITDA margin despite a 13% revenue decline, driven by cost control and international expansion. RTD beverage growth and licensing deals are set to boost future revenue, with debt refinancing expected to improve cash flow.
Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information
WESTBROOK, Maine, May 01, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a provider of consumer health care and lifestyle products, announced today that it pla...
Synergy CHC Earnings Call Transcript: Q4 2024
Eighth consecutive profitable quarter achieved despite a 19% annual revenue decline, impacted by Focus Factor rebranding and retailer de-inventorying. Adjusted EBITDA rose 21% for the year, and new product launches and expanded distribution are expected to drive growth in 2025.
Synergy CHC Earnings Call Transcript: Q3 2024
Q3 revenue and EBITDA declined year-over-year due to a one-time rebranding and retailer de-inventoring, but profitability was maintained. Expanded retail partnerships and IPO proceeds strengthened the balance sheet, with growth expected to resume in 2025.
Synergy CHC Corp. Announces Closing of Initial Public Offering
WESTBROOK, Maine, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy”), a provider of consumer health care, beauty, and lifestyle products, announced today the completion of ...
Synergy CHC Corp. Prices $10.35 Million Initial Public Offering
WESTBROOK, Maine, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (“Synergy”), a provider of consumer health care, beauty, and lifestyle products, announced today the pricing of an initial public ...